A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation...

Area of Science:

• Radiation Oncology
• Medical Physics
• Oncology

Background:

• Nasopharyngeal carcinoma (NPC) treatment involves complex radiotherapy planning.
• Intensity-modulated radiotherapy (IMRT) is a standard technique for NPC.
• Comparing different IMRT fractionation methods is crucial for optimizing patient outcomes.

Purpose of the Study:

• To compare acute and late toxicities between sequential (SEQ) and simultaneous integrated boost (SIB) IMRT for NPC.
• To evaluate the efficacy of SEQ-IMRT versus SIB-IMRT in terms of survival outcomes.

Main Methods:

• Randomized trial comparing SEQ-IMRT and SIB-IMRT in Stage I-IVB NPC patients.
• SEQ-IMRT involved sequential boosts to high-risk planning target volumes (PTVs).
• SIB-IMRT delivered simultaneous integrated boosts to both low- and high-risk PTVs.

Main Results:

• No significant difference in grade 3-4 acute toxicities between SEQ-IMRT and SIB-IMRT (59.8% vs. 58.9%).
• Common grade 3-4 late toxicities included hearing loss, temporal lobe injury, cranial nerve injury, and xerostomia, with some variations between arms.
• 3-year progression-free survival (72.7% vs. 73.4%) and overall survival (86.3% vs. 83.6%) were comparable.

Conclusions:

• Both SEQ-IMRT and SIB-IMRT achieve excellent survival outcomes with manageable late toxicities in NPC.
• SIB-IMRT is recommended as the preferred technique for NPC treatment due to its convenience.
• Adherence to dose-volume constraints for critical organs is essential for SIB-IMRT.